Skip to content

DYN

Dyne Therapeutics, Inc.

Stock

$15.20−0.62 (−3.92%)Close Oct 2, 2026

Free cash flow, 2025
−$405M

Free cash flow

Free cash flow by fiscal year

PeriodFree cash flowYoY
2025−$405M—
2024−$295M—
2023−$189M—
2022−$157M—
2021−$123M—
2020−$48M—
2019−$13M—